HRP20040575A2 - Pharmaceutical compositions based on azetidine derivatives - Google Patents

Pharmaceutical compositions based on azetidine derivatives Download PDF

Info

Publication number
HRP20040575A2
HRP20040575A2 HR20040575A HRP20040575A HRP20040575A2 HR P20040575 A2 HRP20040575 A2 HR P20040575A2 HR 20040575 A HR20040575 A HR 20040575A HR P20040575 A HRP20040575 A HR P20040575A HR P20040575 A2 HRP20040575 A2 HR P20040575A2
Authority
HR
Croatia
Prior art keywords
composition according
azetidine
general formula
pharmaceutical composition
azetidine derivative
Prior art date
Application number
HR20040575A
Other languages
English (en)
Croatian (hr)
Inventor
Sophie Cote
Valurie Bobineau
Maria Teresa Peracchia
Klaus Wirth
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP20040575A2 publication Critical patent/HRP20040575A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20040575A 2001-12-21 2002-12-20 Pharmaceutical compositions based on azetidine derivatives HRP20040575A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116638A FR2833842B1 (fr) 2001-12-21 2001-12-21 Compositions pharmaceutiques a base de derives d'azetidine
PCT/FR2002/004514 WO2003053431A2 (fr) 2001-12-21 2002-12-20 Compositions pharmaceutiques a base de derives d'azetidine

Publications (1)

Publication Number Publication Date
HRP20040575A2 true HRP20040575A2 (en) 2004-10-31

Family

ID=8870824

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040575A HRP20040575A2 (en) 2001-12-21 2002-12-20 Pharmaceutical compositions based on azetidine derivatives

Country Status (31)

Country Link
EP (1) EP1458413B1 (da)
JP (1) JP5021887B2 (da)
KR (1) KR20040068308A (da)
CN (1) CN100388918C (da)
AP (1) AP1754A (da)
AR (1) AR037687A1 (da)
AU (1) AU2002364866B2 (da)
BR (1) BR0215048A (da)
CA (1) CA2470443A1 (da)
CO (1) CO5590911A2 (da)
DE (1) DE60233071D1 (da)
DK (1) DK1458413T3 (da)
EA (1) EA006510B1 (da)
EC (1) ECSP045162A (da)
FR (1) FR2833842B1 (da)
HR (1) HRP20040575A2 (da)
HU (1) HUP0402586A3 (da)
IL (1) IL162563A0 (da)
MA (1) MA27086A1 (da)
ME (1) MEP16608A (da)
MX (1) MXPA04005558A (da)
MY (1) MY138172A (da)
NO (1) NO20042781L (da)
NZ (1) NZ533225A (da)
OA (1) OA12750A (da)
PL (1) PL203248B1 (da)
RS (1) RS55504A (da)
TW (1) TWI256304B (da)
UA (1) UA77736C2 (da)
WO (1) WO2003053431A2 (da)
ZA (1) ZA200404338B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
EP1718609A1 (en) 2004-02-17 2006-11-08 Laboratorios Del Dr. Esteve, S.A. Substituted azetidine compounds, their preparation and use as medicaments
FR2879932B1 (fr) * 2004-12-27 2007-03-23 Aventis Pharma Sa Formulations injectable ou administrable par voie orale de derives d'azetidine
AU2006264649A1 (en) 2005-06-30 2007-01-11 Prosidion Limited GPCR agonists
EP2114933B1 (en) 2007-01-04 2011-09-07 Prosidion Ltd Piperidine gpcr agonists
PE20081849A1 (es) 2007-01-04 2009-01-26 Prosidion Ltd Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
EA016507B1 (ru) 2007-01-04 2012-05-30 Прозидион Лимитед Пиперидиновые агонисты gpcr
CL2008000018A1 (es) 2007-01-04 2008-08-01 Prosidion Ltd Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
FR2928149B1 (fr) 2008-02-29 2011-01-14 Sanofi Aventis Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2946650B1 (fr) * 2009-06-16 2011-08-19 Sanofi Aventis Esters derives d'azetidines, leur preparation et leur application en therapeutique.
UA153183U (uk) 2022-10-27 2023-05-31 Андрій Валерійович Максимов Стаканчик для приготування напою

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73668B (da) * 1978-11-21 1984-03-28 Hoffmann La Roche
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) * 1998-01-20 1999-10-31 Pliva Pharm & Chem Works 1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
JP2002520377A (ja) * 1998-07-14 2002-07-09 イーエム インダストリーズ インコーポレイテッド ミクロ分散薬物送達システム
FR2783246B1 (fr) * 1998-09-11 2000-11-17 Aventis Pharma Sa Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805810B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

Also Published As

Publication number Publication date
EP1458413B1 (fr) 2009-07-22
MY138172A (en) 2009-04-30
NZ533225A (en) 2007-02-23
MXPA04005558A (es) 2004-12-06
PL203248B1 (pl) 2009-09-30
CN1602206A (zh) 2005-03-30
WO2003053431A3 (fr) 2003-12-18
WO2003053431A2 (fr) 2003-07-03
CO5590911A2 (es) 2005-12-30
FR2833842B1 (fr) 2004-02-13
JP5021887B2 (ja) 2012-09-12
HUP0402586A3 (en) 2011-05-30
AR037687A1 (es) 2004-12-01
AP2004003066A0 (en) 2004-06-30
PL372708A1 (en) 2005-07-25
AU2002364866B2 (en) 2006-11-30
KR20040068308A (ko) 2004-07-30
IL162563A0 (en) 2005-11-20
DE60233071D1 (de) 2009-09-03
DK1458413T3 (da) 2009-11-23
TWI256304B (en) 2006-06-11
ECSP045162A (es) 2004-08-27
HUP0402586A2 (hu) 2005-03-29
MA27086A1 (fr) 2004-12-20
AU2002364866A1 (en) 2003-07-09
BR0215048A (pt) 2004-11-03
AP1754A (en) 2007-07-18
EA200400843A1 (ru) 2004-12-30
OA12750A (fr) 2006-07-03
CA2470443A1 (fr) 2003-07-03
FR2833842A1 (fr) 2003-06-27
RS55504A (sr) 2007-06-04
EA006510B1 (ru) 2005-12-29
TW200301108A (en) 2003-07-01
EP1458413A2 (fr) 2004-09-22
HK1070840A1 (zh) 2005-06-30
NO20042781L (no) 2004-09-20
ZA200404338B (en) 2005-06-02
CN100388918C (zh) 2008-05-21
UA77736C2 (en) 2007-01-15
JP2005516945A (ja) 2005-06-09
MEP16608A (en) 2010-06-10

Similar Documents

Publication Publication Date Title
US20110053903A1 (en) Pharmaceutical compositions based on azetidine derivatives
JP5021887B2 (ja) アゼチジン誘導体に基づく医薬組成物
US20050037062A1 (en) Emulsifying systems containing azetidine derivatives
AU2004262498B2 (en) Semi-solid systems containing azetidine derivatives
JP2008525390A (ja) アゼチジン誘導体の注射可能又は経口送達可能な製剤
HK1070840B (en) Pharmaceutical compositions based on azetidine derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20091216

Year of fee payment: 8

OBST Application withdrawn